Radioimmunoassay for orexin A

doi:10.1016/S0024-3205(99)00673-6

Life Sciences

Volume 66, Issue 10, 28 January 2000, Pages 897-904

https://doi.org/10.1016/S0024-3205(99)00673-6 Get rights and content

Abstract

A radioimmunoassay for orexin A has been developed. Anti-orexin A antiserum was raised in New Zealand white rabbits immunized with a conjugate of synthetic orexin A with bovine serum albumin. This antibody did not crossreact with orexin B,hypothalamic hormones,pituitary hormones, neuropeptides or gut hormones. Radioiodination of orexin A was performed with the chloramin T method, followed by purification of radioiodinated material on Sephadex G-25 column. Orexin A was extracted from tissues using acid-acetone. The assay was performed with a double antibody system. The dilution curve of acid-acetone-extracts of rat hypothalamus in the radioimmunoassay system was parallel to the standard curve. The recovery of tissue orexin A was about 80%,and the intra-assay and inter-assay variations were 5.2% and 7.8%, respectively. Orexin A was found in the hypothalamus, cerebrum and testis. These data suggest that this assay system is suitable for the measurement of tissue orexin A and that orexin A is found in the central nervous system and testis.

References (8)

T. Sakurai et al.
Cell
(1998)
J.S. Flier et al.
Cell
(1998)
M Rosenbaum et al.
New Engl. J Med.
(1997)
T. Mitsuma et al.
Med. Sci. Res.
(1988)

There are more references available in the full text version of this article.

Cited by (35)

Orexin-A facilitates emergence of the rat from isoflurane anesthesia via mediation of the basal forebrain
2016, Neuropeptides
Citation Excerpt :
Then, the samples were centrifuged at 3000 × g for 10 min at 4 °C. The plasma was separated, immediately frozen and stored at − 80 °C until orexin concentrations were measured (Mitsuma et al., 2000; Wang et al., 2014). Plasma orexin-A and orexin-B levels were measured using the RK-003-30 Orexin-A/Hypocretin-1 and RK-003-32 Orexin-B/Hypocretin-2 radioimmunoassay kit (Phoenix Pharmaceuticals, Inc., Burlingame, CA).
Previous studies have demonstrated that orexinergic neurons involve in promoting emergence from anesthesia of propofol, an intravenous anesthetics, while whether both of orexin-A and orexin-B have promotive action on emergence via mediation of basal forebrain (BF) in isoflurane anesthesia has not been elucidated. In this study, we observed c-Fos expressions in orexinergic neurons following isoflurane inhalation (for 0, 30, 60, and 120 min) and at the time when the righting reflex returned after the cessation of anesthesia. The plasma concentrations of orexin-A and -B in anesthesia-arousal process were measured by radioimmunoassay. Orexin-A and -B (30 or 100 pmol) or the orexin receptor-1 and -2 antagonist SB-334867A and TCS-OX2-29 (5 or 20 μg) were microinjected into the basal forebrain respectively. The effects of them on the induction (loss of the righting reflex) and the emergence time (return of the righting reflex) under isoflurane anesthesia were observed. The results showed that the numbers of c-Fos-immunoreactive orexinergic neurons in the hypothalamus decreased over time with continued isoflurane inhalation, but restored at emergence. Similar alterations were observed in changes of plasma orexin-A concentrations but not in orexin-B during emergence. Administration of orexins had no effect on the induction time, but orexin-A facilitated the emergence of rats from isoflurane anesthesia while orexin-B didn't. Conversely, microinjection of the orexin receptor-1 antagonist SB-334867A delayed emergence from isoflurane anesthesia. The results indicate that orexin-A plays a promotive role in the emergence of isoflurane anesthesia and this effect is mediated by the basal forebrain.
Novel localization of orexin A in the tubular cytotypes of the rat testis
2010, Regulatory Peptides
Citation Excerpt :
The neuroendocrine cells of the urethro-prostatic complex, the principal cells of the epididymis, and the testis have been shown to provide a source of OXA in this tract [16,17,20]. However, the testis is likely the tissue that, after the brain, holds the highest orexin expression levels reported so far [21,25]. A strong OXA-immunoreactivity was detected in Leydig cells and spermatocytes of rat testis throughout postnatal development [16].
The hypothalamic peptides orexin A (OXA) and orexin B (OXB), deriving from the proteolytic cleavage of the precursor molecule prepro-orexin, have also been localized in multiple cerebral areas and peripheral organs. They regulate food intake, arterial blood pressure, heart rate, sleep/wake cycle, sexual behavior, arousal, and the hypothalamic/hypophyseal axes. Prepro-orexin mRNA expression and OXA-immunoreactivity were previously detected in the rat testis at different ages of postnatal development, with strong peptide signal in Leydig cells and spermatocytes. In this study, OXA-immunoreactivity was found in Sertoli cells and spermatids of rat testis. Hematoxylin-counterstained sections revealed OXA positive spermatids in the stages of the germinal epithelium cycle ranging from the VIIth to the XIVth. The expression of prepro-orexin mRNA and of the protein in the testis tissue was ascertained by reverse-transcription polymerase chain reaction and Western blotting analysis, respectively. Although the functional role of OXA in the male genital tract still remains to be elucidated, our findings provide the first evidence that Sertoli cells, belonging to the tubular compartment of testis, represent an important source of OXA, thus suggesting the potential involvement of the peptide in the control of seminiferous epithelium development.
Expression of orexin A and its receptor 1 in the rat epididymis
2009, Regulatory Peptides
Expression of orexin-A and orexin receptors in the kidney and the presence of orexin-A-like immunoreactivity in human urine
2006, Peptides
Orexin-A (hypocretin-1), a neuropeptide with stimulatory actions on arousal and appetite, was originally shown to be specifically expressed in the hypothalamus. We studied expression of orexin-A and orexin receptors in the kidney and the presence of orexin-A-like immunoreactivity in human urine. Immunocytochemistry showed that orexin-A-like immunoreactivity and two types of orexin receptors (types 1 and 2) were localized in the tubules of the human kidney obtained at autopsy. Orexin-A-like immunoreactivity was detected in human kidneys (21.3 ± 6.2 fmol/g wet weight, mean ± S.E.M., n = 4) and rat kidneys (16.2 ± 1.6 fmol/g wet weight, n = 5) by radioimmunoassay, although the levels were much lower than the levels in the brain. Orexin-A-like immunoreactivity was present in the urine obtained from male healthy volunteers (67.8 ± 4.5 pmol/l, n = 5). Reverse phase high-performance liquid chromatography showed that most of orexin-A-like immunoreactivity of the urine extract was eluted earlier than authentic orexin-A, suggesting that orexin-A-like immunoreactivity in urine was modified to hydrophilic forms. Reverse transcriptase polymerase chain reaction showed expression of orexin receptors 1 and 2 mRNAs in the human kidney. These findings suggest that orexin-A is produced by the renal tubular cells and secreted into urine. Orexin-A may act on the kidney in the autocrine or paracrine fashion, or via the urine (urocrine fashion).
Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice
2005, Pain
Orexins are neuropeptides that are mostly expressed in the posterior and lateral hypothalamus, and related to the central control of appetite, arousal, and antinociception. Orexin neurons projected to the tuberomammillary nucleus and orexins may release histamine from the histamine neurons in this nucleus. Histamine is known to cause hypernociception. The roles of histamine H1 and H2 receptors in the orexin A-induced antinociception, however, have not been clarified yet. Here we studied the effects of histamine H1 and H2 receptors on orexin A-produced antinociception using histamine receptor knockout mice in four assays of nociception; the hot-plate, the tail-flick, the tail-pressure and the capsaicin tests. Furthermore we studied effects of histamine H1 and H2 receptor antagonists on orexin A-produced antinociception in C57BL/6 mice. The antinociceptive effects of i.c.v. orexin A were greater in histamine H1 receptor or H2 receptor knockout mice than in the wild-type mice in all four assays of pain. Furthermore, treatment of C57BL/6 mice with a combination of i.c.v. orexin A and d-chlorpheniramine (a histamine H1 receptor antagonist) or cimetidine (a histamine H2 receptor antagonist) showed a greater antinociception than i.c.v. orexin A alone in all four assays. These findings suggest the possibility that orexin A may activate H1 and H2 receptors in the supraspinal levels through the release of histamine from neurons, which might attenuate the antinociceptive effects of orexin A. Thus, the blocking of the histamine H1 or H2 receptor may produce antinociception and enhance the orexin A-induced antinociception.
Expression of orexin receptors in the brain and peripheral tissues of the male sheep
2005, Regulatory Peptides
Orexins exert their effects through two specific receptors (OX1R and OX2R) that have been found mainly in the brain and also in peripheral tissues of rats and humans. Here, we demonstrate expression of mRNA encoding for ovine OX1R and OX2R in central and peripheral tissues of sheep. Gene expression for orexin receptors in the hypothalamus and the preoptic area was localised by in situ hybridisation. OX1R was detected in arcuate nuclei (ARC), median eminence (ME), the lateral hypothalamic nuclei and preoptic area (POA) and it was scattered along the third ventricle from the paraventricular (PVN) to the ventromedial hypothalamic nuclei (VMH). OX2R was localised in the PVN, ARC, ME, ventral VMH and a small region of the ventral POA. Gene expression for OX1R and OX2R in central and peripheral tissues was analysed using quantitative real time RT-PCR. Both orexin receptor genes were expressed in the hypothalamus, POA, hippocampus, amygdala, olfactory bulb, pineal gland and recess and pituitary gland, whereas only OX1R mRNA was detected in the testis, kidney and adrenal gland. The expression of the genes for orexin receptors in this range of ovine tissues suggests roles for orexins in multiple physiological functions, with actions at both central and peripheral levels.

View all citing articles on Scopus

View full text

Radioimmunoassay for orexin A

Abstract

Cell

Cell

New Engl. J Med.

Med. Sci. Res.